Cargando…

Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack

OBJECTIVE: Cognitive impairment after stroke/transient ischemic attack (TIA) has a high prevalence. Cystatin C (CysC) has been found as a novel biomarker of neurodegenerative diseases, such as dementia and Alzheimer’s disease. We aimed to explore the possible correlations of serum CysC level with co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Lijun, Dong, Yanhong, Pan, Yuesong, Yan, Hongyi, Meng, Xia, Li, Hao, Zhao, Xingquan, Wang, Yilong, Wang, Yongjun, Liao, Xiaoling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329915/
https://www.ncbi.nlm.nih.gov/pubmed/37435549
http://dx.doi.org/10.2147/NDT.S412825
_version_ 1785070118014812160
author Zuo, Lijun
Dong, Yanhong
Pan, Yuesong
Yan, Hongyi
Meng, Xia
Li, Hao
Zhao, Xingquan
Wang, Yilong
Wang, Yongjun
Liao, Xiaoling
author_facet Zuo, Lijun
Dong, Yanhong
Pan, Yuesong
Yan, Hongyi
Meng, Xia
Li, Hao
Zhao, Xingquan
Wang, Yilong
Wang, Yongjun
Liao, Xiaoling
author_sort Zuo, Lijun
collection PubMed
description OBJECTIVE: Cognitive impairment after stroke/transient ischemic attack (TIA) has a high prevalence. Cystatin C (CysC) has been found as a novel biomarker of neurodegenerative diseases, such as dementia and Alzheimer’s disease. We aimed to explore the possible correlations of serum CysC level with cognitive impairment in patients who had mild ischemic stroke and TIA after 1 year. METHODS: We measured serum CysC level in 1025 participants with a minor ischemic stroke/TIA from enrolled from the Impairment of Cognition and Sleep (ICONS) study of the China National Stroke Registry-3 (CNSR-3). They were divided into four groups according to quartiles of baseline CysC levels. Patients’ cognitive functions were assessed by Montreal Cognitive Assessment (MoCA)-Beijing at day 14 and at 1 year. Multiple logistic regression models were performed to evaluate the relationship between CysC and post-stroke cognitive impairment (PSCI) at 1-year follow-up. RESULTS: Cognitive impairment was defined as MoCA-Beijing ≤22. Most patients were in 60s (61.52±10.97 years old) with a median (interquartile range) National Institute of Health Stroke Scale(NIHSS) score of 3.00 (4.00) and greater than primary school level of education, and 743 participants (72.49%) were male. Among the 1025 participants, 331 participants (32.29%) patients suffered PSCI at 1-year follow-up. A U-shaped association was observed between CysC and 1-year PSCI [quartile (Q)1 vs Q3: adjusted odds ratio (aOR) 2.69, 95% CI 1.67–4.34, p < 0.0001; Q2 vs Q3: aOR 1.63, 95% CI 1.03–2.57, p = 0.0354; Q4 vs Q3: aOR 1.83, 95% CI 1.16–2.87, p = 0.009]. Moreover, the U-shaped trends were also found between CysC level and the subscores of attention, recall, abstraction and language in MoCA. CONCLUSION: CysC showed a U-shaped correlation with 1-year overall cognitive function. It is probable that measurement of the serum CysC level would aid in the early diagnosis of PSCI.
format Online
Article
Text
id pubmed-10329915
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103299152023-07-11 Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack Zuo, Lijun Dong, Yanhong Pan, Yuesong Yan, Hongyi Meng, Xia Li, Hao Zhao, Xingquan Wang, Yilong Wang, Yongjun Liao, Xiaoling Neuropsychiatr Dis Treat Original Research OBJECTIVE: Cognitive impairment after stroke/transient ischemic attack (TIA) has a high prevalence. Cystatin C (CysC) has been found as a novel biomarker of neurodegenerative diseases, such as dementia and Alzheimer’s disease. We aimed to explore the possible correlations of serum CysC level with cognitive impairment in patients who had mild ischemic stroke and TIA after 1 year. METHODS: We measured serum CysC level in 1025 participants with a minor ischemic stroke/TIA from enrolled from the Impairment of Cognition and Sleep (ICONS) study of the China National Stroke Registry-3 (CNSR-3). They were divided into four groups according to quartiles of baseline CysC levels. Patients’ cognitive functions were assessed by Montreal Cognitive Assessment (MoCA)-Beijing at day 14 and at 1 year. Multiple logistic regression models were performed to evaluate the relationship between CysC and post-stroke cognitive impairment (PSCI) at 1-year follow-up. RESULTS: Cognitive impairment was defined as MoCA-Beijing ≤22. Most patients were in 60s (61.52±10.97 years old) with a median (interquartile range) National Institute of Health Stroke Scale(NIHSS) score of 3.00 (4.00) and greater than primary school level of education, and 743 participants (72.49%) were male. Among the 1025 participants, 331 participants (32.29%) patients suffered PSCI at 1-year follow-up. A U-shaped association was observed between CysC and 1-year PSCI [quartile (Q)1 vs Q3: adjusted odds ratio (aOR) 2.69, 95% CI 1.67–4.34, p < 0.0001; Q2 vs Q3: aOR 1.63, 95% CI 1.03–2.57, p = 0.0354; Q4 vs Q3: aOR 1.83, 95% CI 1.16–2.87, p = 0.009]. Moreover, the U-shaped trends were also found between CysC level and the subscores of attention, recall, abstraction and language in MoCA. CONCLUSION: CysC showed a U-shaped correlation with 1-year overall cognitive function. It is probable that measurement of the serum CysC level would aid in the early diagnosis of PSCI. Dove 2023-07-05 /pmc/articles/PMC10329915/ /pubmed/37435549 http://dx.doi.org/10.2147/NDT.S412825 Text en © 2023 Zuo et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zuo, Lijun
Dong, Yanhong
Pan, Yuesong
Yan, Hongyi
Meng, Xia
Li, Hao
Zhao, Xingquan
Wang, Yilong
Wang, Yongjun
Liao, Xiaoling
Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title_full Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title_fullStr Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title_full_unstemmed Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title_short Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack
title_sort impact of serum cystatin c level on long-term cognitive impairment after acute ischemic stroke and transient ischemic attack
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329915/
https://www.ncbi.nlm.nih.gov/pubmed/37435549
http://dx.doi.org/10.2147/NDT.S412825
work_keys_str_mv AT zuolijun impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT dongyanhong impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT panyuesong impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT yanhongyi impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT mengxia impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT lihao impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT zhaoxingquan impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT wangyilong impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT wangyongjun impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack
AT liaoxiaoling impactofserumcystatinclevelonlongtermcognitiveimpairmentafteracuteischemicstrokeandtransientischemicattack